Background In response to increased prenatal drug use since the 2000s, states have
adopted treatment-oriented laws giving pregnant and postpartum people priority access to …

Background: Buprenorphine is a key medication to treat opioid use disorder, but little is
known about how treatment quality varies across sociodemographic groups. Objective: We …

Policy Points Over the past several decades, states have adopted policies intended to
address prenatal drug use. Many of these policies have utilized existing child welfare …

Objective Infants affected by prenatal alcohol and drug use are more likely to be removed
from parental custody than those in the general population, although it is unclear whether …

Introduction States' approaches to addressing prenatal substance use are widely
heterogeneous, ranging from supportive policies that enhance access to substance use …

OBJECTIVE: To examine demographic and clinical precursors to pregnancy-associated
deaths overall and when pregnancy-related deaths are excluded. METHODS: We …

We described Medicaid-insured women by receipt of perinatal opioid use disorder (OUD)
treatment; and trends and disparities in treatment. Using 2007 to 2012 Medicaid Analytic …

Over the past few decades, maternal opioid use and Neonatal Abstinence Syndrome (NAS)
have significantly increased. However, few studies have examined prevalence trends by …

This study examined trends and disparities in opioid use disorder (OUD) outcomes among
pregnant women and analyzed the association of these outcomes with punitive child welfare …

Among mothers with substance use disorder (SUD), most who likely need postpartum SUD
treatment did not receive it, according to a recent study published in Women's Health …